Brain tumor, breast cancer, colon cancer, congenital heart disease, heart arrhythmia. See more conditions.
The research interests of William V. Bobo, M.D., M.P.H., are focused on examining and predicting the clinical effects — both beneficial and harmful — of medications used to treat people with severe mood disorders. Dr. Bobo's research examines the effects of selective serotonin reuptake inhibitors (SSRIs) and serotonin and norepinephrine reuptake inhibitors (SNRIs) on vulnerable populations such as pregnant women, and applies artificial intelligence and other advanced computational approaches to health care.
In collaboration with researchers at the University of Illinois at Urbana-Champaign, Dr. Bobo has developed a machine learning workflow that has shown considerable promise for accurately predicting the eventual treatment outcome of adults with major depression who receive SSRI or SNRI antidepressants. This workflow is now being turned into a practical tool that may aid clinical decision-making. Dr. Bobo's epidemiology studies are addressing important questions about the fetal, neonatal and developmental safety of antidepressants that are commonly used by pregnant women.
Learn about clinical trials that address specific scientific questions about human health and disease.
See my studies.
Explore all research studies at Mayo Clinic.
See the peer-reviewed findings I have published as a result of my research.
Review my research fingerprint, network, grants, projects, publications, Scopus profile, and Altmetrics scores and badges.
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products and services advertised.
A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.org," "Mayo Clinic Healthy Living," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.